1. Home
  2. MYNZ vs CHNR Comparison

MYNZ vs CHNR Comparison

Compare MYNZ & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • CHNR
  • Stock Information
  • Founded
  • MYNZ 2021
  • CHNR N/A
  • Country
  • MYNZ Germany
  • CHNR China
  • Employees
  • MYNZ N/A
  • CHNR N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • CHNR Precious Metals
  • Sector
  • MYNZ Health Care
  • CHNR Basic Materials
  • Exchange
  • MYNZ Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • MYNZ 5.5M
  • CHNR 4.6M
  • IPO Year
  • MYNZ 2021
  • CHNR 1995
  • Fundamental
  • Price
  • MYNZ $1.92
  • CHNR $3.68
  • Analyst Decision
  • MYNZ Buy
  • CHNR
  • Analyst Count
  • MYNZ 2
  • CHNR 0
  • Target Price
  • MYNZ $14.00
  • CHNR N/A
  • AVG Volume (30 Days)
  • MYNZ 155.6K
  • CHNR 37.9K
  • Earning Date
  • MYNZ 07-22-2025
  • CHNR 05-15-2025
  • Dividend Yield
  • MYNZ N/A
  • CHNR N/A
  • EPS Growth
  • MYNZ N/A
  • CHNR N/A
  • EPS
  • MYNZ N/A
  • CHNR N/A
  • Revenue
  • MYNZ $893,991.00
  • CHNR N/A
  • Revenue This Year
  • MYNZ $26.06
  • CHNR N/A
  • Revenue Next Year
  • MYNZ $4.97
  • CHNR N/A
  • P/E Ratio
  • MYNZ N/A
  • CHNR N/A
  • Revenue Growth
  • MYNZ N/A
  • CHNR N/A
  • 52 Week Low
  • MYNZ $1.34
  • CHNR $3.35
  • 52 Week High
  • MYNZ $20.08
  • CHNR $9.04
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 57.87
  • CHNR 43.59
  • Support Level
  • MYNZ $1.35
  • CHNR $3.35
  • Resistance Level
  • MYNZ $2.15
  • CHNR $3.71
  • Average True Range (ATR)
  • MYNZ 0.13
  • CHNR 0.30
  • MACD
  • MYNZ 0.10
  • CHNR -0.03
  • Stochastic Oscillator
  • MYNZ 71.67
  • CHNR 29.41

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

Share on Social Networks: